Ketamine Versus Placebo for Treatment Resistant Major Depressive Disorder
Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
Ketamine infusions resulted in an acute reduction in global depression scores and in severity
of suicidal ideation. The investigators therefore plan to investigate the feasibility and
efficacy of repeated intravenous administration of ketamine in severely depressed, treatment
resistant patients. The results of the study could lead to development of new strategies for
treating depression.